1. Home
  2. FAC vs RGNX Comparison

FAC vs RGNX Comparison

Compare FAC & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Factorial Energy Inc. Class A Common Stock

FAC

Factorial Energy Inc. Class A Common Stock

N/A

Current Price

$5.41

Market Cap

561.9M

Sector

Miscellaneous

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.73

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAC
RGNX
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.9M
528.6M
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
FAC
RGNX
Price
$5.41
$9.73
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.75
AVG Volume (30 Days)
460.0K
2.1M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
N/A
$51.21
Revenue Next Year
N/A
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$4.24
$5.46
52 Week High
$15.40
$16.19

Technical Indicators

Market Signals
Indicator
FAC
RGNX
Relative Strength Index (RSI) 27.98 44.48
Support Level $4.27 $7.95
Resistance Level $5.76 $11.00
Average True Range (ATR) 0.65 0.76
MACD 0.15 -0.33
Stochastic Oscillator 49.55 32.97

Price Performance

Historical Comparison
FAC
RGNX

About FAC Factorial Energy Inc. Class A Common Stock

Factorial Energy Inc is an American solid-state battery innovator backed by In-Q-Tel - the not-for-profit strategic investor for the U.S. national security community and America's allies - and Mercedes-Benz, Stellantis, Hyundai, and Kia. Through its proprietary FEST and Solstice platforms, engineered for scalable manufacturing, it delivers industry performance across defense, space, and energy storage applications. Mercedes-Benz's real-world road testing in a lightly modified test vehicle achieved over 1,200 km of range on a single charge, while Stellantis-lab testing verified 77 Ah cells demonstrating high energy density, fast-charging, and robust use for energy and power performance across temperature extremes.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: